MRI Dye Puts Kidney Patients at Risk
In February 2007, federal health officials warned doctors about the risk of a dangerous skin disease in kidney patients injected with gadolinium-based MRI dyes.
Gadolinium is a metallic substance used as a contrast agent in certain MRI dyes to provide a clearer picture of internal organs. Dyes containing gadolinium have been used since 1988 and there are currently five FDA approved gadolinium-based dyes on the market.
The FDA issued a public health advisory last year after reports surfaced in Europe linking gadolinium to a rare disease called nephrogenic systemic fibrosis. The disease has also been reported in more than two dozen dialysis patients in the United States.
A disease-tracking registry at Yale has recorded over 200 cases of nephrogenic systemic fibrosis. However, because the disease is so rare, experts suspect that it may go undiagnosed and thus underreported.
Injured by gadolinium? Contact a Gadolinium attorney for a complimentary case evaluation.